June 20-25, 2010 • Honolulu, Hawai’i
13
islh 2013 • MAY 10-12
continuing education
TARGET AUDIENCE
Physicians, Laboratory Directors, LaboratoryManagers
and Supervisors, Clinical Laboratory Scientists/Medical
Technologists, Residents and Fellows.
LEARNING OBJECTIVES
1.
Define new technological developments in
laboratory hematology testing.
2.
Identify ways to implement technological advances
in the routine hematology laboratory.
3.
Describe the latest diagnostics capabilities and
directions in cellular analysis and flow cytometry.
4.
Identify new ways to improve laboratory diagnosis
in hemostasis and molecular pathology.
CME ACCREDITATION STATEMENT
AMA PRA Category 1 Credits™
This activity was planned and implemented in
accordance with the Essential Areas and policies
of the Accreditation Council for Continuing Medical
Education (ACCME) through the joint sponsorship
of the American Association for Clinical Chemistry
(
AACC) and the International Society for Laboratory
Hematology. AACC is accredited by the ACCME to
provide continuing medical education for physicians.
AACC designates this live activity for a maximum of
13.0
AMA PRA Category 1 Credit(s)TM. Physicians
should claim only the credit commensurate with the
extent of their participation in the activity.
ACCENT® credit hours
AACC designates this activity for a maximum of 13.0
ACCENT® credit hours. AACC is an approved provider
of continuing education (CE) for clinical laboratory
scientists licensed in states that require documentation
of CE, including California, Florida, Louisiana, Montana,
Nevada, North Dakota, Rhode Island, Tennessee, and
West Virginia. ACCENT® credit is also recognized by
several organizations: AAB, ABCC, ACS, AMT, ASCLS,
ASCP, ASM, CAP, IFCC, and NRCC.
CLAIMING CREDITS
All credits will be claimed online after the conference.
please visit
for more information.
CONTINUING MEDICAL EDUCATION
